Evidence-based clinical practice parameter guidelines for the treatment of patients with metastatic brain tumors: introduction
Bibliographic record
Abstract
Properly understood and employed, evidence-based medicine (EBM) is a tool of considerable value for medicine and neuro-oncology [1]. It provides a secure, scientificallydefensible base for clinical practice and practice improvement. However, pursued on an individual case-by-case basis, in purest form, it can be inefficient and time consuming, particularly for health providers with extremely busy clinical practices. Clinical guidelines based on the best evidence available, developed and regularly updated by subject matter experts, focusing on common and important clinical scenarios and questions, have the potential to be very desirable, useful, and efficient EBM tools for optimizing patient care. Clinical practice parameter guidelines are defined as ‘systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific individual circumstances’ [2]. An advantage of utilizing guidelines in clinical decision-making over sole reliance on randomized controlled trial (RCT) results, is that they take professional experience into account in an aggregate and more systematic manner, rather than on an individual or ad hoc basis [3]. Not only are more ‘‘experts’’ involved in the consensus process (diluting out outliers in opinion), but, in an evidence-based guidelines development process, the opinions solicited are the experts’ opinions about the collected evidence in the literature, rather than simply their own personal opinions regarding the subject. Multidisciplinary, evidence-linked clinical practice parameter guidelines, based on the most rigorous evidencebased methodology, offer the potential of reducing unexplainable variation in clinical practice while elevating the quality of patient care to the highest levels supported by the best available, and most up-to-date, evidence. They also have the potential to clearly point out where critical evidence ‘‘gaps’’ exist in areas important to clinical care that can then subsequently be filled by directed research planning and investment [4]. The goal of this guideline initiative is to optimize the care and outcome of our patients with brain metastases, by providing the most methodologically valid, evidence-linked treatment recommendations in a user-friendly and comprehensive manner, for real-world clinical scenarios encountered by clinicians and patients every day. The healthcare policy implications of clinical practice parameter guidelines are very real and deserve the careful attention of both individual practitioners and our national medical professional organizations. Legislation efforts currently active in Washington include language focusing on development and inclusion of ‘‘appropriateness criteria’’ as a means of restricting medical care and reducing medical costs. They also include language focusing on the development and funding of comparative effectiveness research analyzing clinical effectiveness, and not just cost effectiveness. Each of these efforts will likely lead to a search for the best available clinical practice guidelines in key public health impact areas for the purpose of improving value for every healthcare dollar spent, as well as reducing cost through practice restriction. It is in our patients’ interest, as well as our own as patient advocates, to ensure the availability of the highest quality guidelines S. N. Kalkanis (&) Department of Neurosurgery, Henry Ford Health System, 2799 West Grand Blvd, K-11, Detroit, MI 48202, USA e-mail: kalkanis@neuro.hfh.edu; skalkan1@hfhs.org
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.012 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".